Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 4Gynecologic 2Head & Neck 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 279Triple Negative Breast Neoplasms 146Neoplasm Metastasis 27Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Inflammatory Breast Neoplasms 15Pancreatic Neoplasms 12Neoplasms 11Endometrial Neoplasms 11Breast Neoplasms, Male 11Colorectal Neoplasms 8Carcinoma, Ductal, Breast 8Stomach Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Lung Neoplasms 7Prostatic Neoplasms 6Melanoma 6Fallopian Tube Neoplasms 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Pathologic Complete Response 5HER2-positive Breast Cancer 5Carcinoma, Ovarian Epithelial 5Esophageal Neoplasms 4Carcinoma, Lobular 4Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Multiple Myeloma 3

Interventions

tremelimumab 1durvalumab 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1EC regimen 1Cisplatin 1Carboplatin 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Carboplatin × Breast × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡